(Q40698212)

22 September 2017

1 reference

title

Oncogenes and anti-oncogenes in human epithelial thyroid tumors (English)

1 reference

22 September 2017

S Said

1

1 reference

22 September 2017

M Schlumberger

series ordinal

2

1 reference

22 September 2017

H G Suarez

series ordinal

3

1 reference

22 September 2017

1 May 1994

1 reference

Journal of Endocrinological Investigation

22 September 2017

1 reference

22 September 2017

17

1 reference

22 September 2017

371-379

1 reference

22 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03349004

22 September 2017

0 references

cites work

Two G protein oncogenes in human endocrine tumors

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Point mutations of ras oncogenes are an early event in thyroid tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Activating point mutations of the gsp oncogene in human thyroid adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

The trk proto-oncogene encodes a receptor for nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Expression of the trk proto-oncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

The ultimobranchial gland and congenital thyroid abnormalities in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Endocrine cells in non-endocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Tyrosine kinase receptor indistinguishable from the c-met protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Mechanism of met oncogene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Allelotype of Human Thyroid Tumors: Loss of Chromosome 11q13 Sequences in Follicular Neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Prevalence of ras gene mutations in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

21 January 2018

A transcriptional tryst

1 reference

https://api.crossref.org/works/10.1007%2FBF03349004

Agent-specific ras oncogene activation in rat thyroid tumours.

21 January 2018

1 reference

12 December 2020

Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism

1 reference

12 December 2020

Molecular basis of epithelial tumorigenesis: the thyroid model

1 reference

12 December 2020

Activated ras oncogenes in human thyroid cancers

1 reference

12 December 2020

Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method

1 reference

12 December 2020

Specific expression of the ret proto-oncogene in human neuroblastoma cell lines

1 reference

12 December 2020

Activated oncogenes in human tumors

1 reference

12 December 2020

Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis

1 reference

12 December 2020

High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.

1 reference

12 December 2020

TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas

1 reference

12 December 2020

Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET

1 reference

12 December 2020

High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis

1 reference

12 December 2020

gsp mutations in human thyroid tumours

1 reference

12 December 2020

High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma

1 reference

12 December 2020

Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland

1 reference

12 December 2020

Presence of mutations in all three ras genes in human thyroid tumors

1 reference

12 December 2020

Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasia

1 reference

12 December 2020

Ras oncogene mutations in benign and malignant thyroid neoplasms

1 reference

12 December 2020

Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

1 reference

12 December 2020

Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter

1 reference

12 December 2020

High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients

1 reference

12 December 2020

Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas

1 reference

12 December 2020

Detection of activated ras oncogenes in human thyroid carcinomas

1 reference

12 December 2020

The trk family of tyrosine protein kinase receptors

1 reference

12 December 2020

The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas

1 reference

12 December 2020

Radiation-associated and 'spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03349004

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference